To include your compound in the COVID-19 Resource Center, submit it here.

Wave starts Phase Ib/IIa testing of HD candidates

Wave Life Sciences Ltd. (NASDAQ:WVE) began the Phase Ib/IIa PRECISION-HD1 and PRECISION-HD2 trials of WVE-120101 and WVE-120102, respectively, to treat

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE